Anadolu Medical Center
The total cost of chondrosarcoma treatment in Turkey varies based on your specific treatment plan. An oncology consultation is approximately $120, a CT scan with contrast is around $550, the IDH1 mutation analysis costs about $650, and comprehensive blood tests, including HBV and HCV, along with an ECG, are approximately $1,150. The overall treatment program is determined after a thorough individual assessment by the medical team.
| Turkey | Austria | Spain | |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,342 |
| Proton therapy for prostate cancer | from $30,000 | from $80,000 | from $70,000 |
| Proton therapy for breast cancer | from $30,000 | from $55,000 | from $85,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone resection | from $8,000 | from $25,000 | from $20,000 |
Author of 40+ peer-reviewed publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy); member of the Turkish Medical Oncology Association and the European Head & Neck Society.
Why patients choose Dr. Bülent Karagöz:
Dr. Mustafa Solak specializes in treating various cancers, including rare cases like Chondrosarcoma, at Hisar Hospital Intercontinental.
Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.
Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.